Pfizer Inc has a consensus price target of $33.27 based on the ratings of 24 analysts. The high is $50 issued by HSBC on July 14, 2023. The low is $24 issued by Cantor Fitzgerald on April 22, 2025. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, UBS, and Goldman Sachs on April 22, 2025, April 8, 2025, and April 8, 2025, respectively. With an average price target of $24.33 between Cantor Fitzgerald, UBS, and Goldman Sachs, there's an implied 5.89% upside for Pfizer Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/22/2025 | Buy Now | 4.44% | Cantor Fitzgerald | Carter Gould59% | → $24 | Initiates | → Neutral | Get Alert |
04/08/2025 | Buy Now | 4.44% | UBS | Trung Huynh66% | $28 → $24 | Maintains | Neutral | Get Alert |
04/08/2025 | Buy Now | 8.79% | Goldman Sachs | Asad Haider 62% | $32 → $25 | Downgrade | Buy → Neutral | Get Alert |
03/18/2025 | Buy Now | — | Guggenheim | Vamil Divan75% | — | Reiterates | Buy → Buy | Get Alert |
03/12/2025 | Buy Now | — | Guggenheim | Vamil Divan75% | — | Reiterates | Buy → Buy | Get Alert |
02/10/2025 | Buy Now | 43.61% | Guggenheim | Vamil Divan75% | $33 → $33 | Reiterates | Buy → Buy | Get Alert |
02/05/2025 | Buy Now | 21.85% | UBS | Colin Bristow39% | $29 → $28 | Maintains | Neutral | Get Alert |
01/28/2025 | Buy Now | 26.2% | Citigroup | Andrew Baum70% | $30 → $29 | Maintains | Neutral | Get Alert |
01/08/2025 | Buy Now | 26.2% | UBS | Colin Bristow39% | $31 → $29 | Maintains | Neutral | Get Alert |
12/18/2024 | Buy Now | 39.25% | Truist Securities | Srikripa Devarakonda44% | $36 → $32 | Maintains | Buy | Get Alert |
12/11/2024 | Buy Now | 43.61% | Guggenheim | Vamil Divan75% | $35 → $33 | Maintains | Buy | Get Alert |
12/10/2024 | Buy Now | 26.2% | B of A Securities | Tim Anderson55% | → $29 | Reinstates | → Neutral | Get Alert |
11/15/2024 | Buy Now | 8.79% | Wolfe Research | Alexandria Hammond46% | → $25 | Initiates | → Underperform | Get Alert |
10/30/2024 | Buy Now | 34.9% | Morgan Stanley | Terence Flynn66% | $30 → $31 | Maintains | Equal-Weight | Get Alert |
10/25/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
10/23/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
10/17/2024 | Buy Now | 39.25% | Bernstein | Courtney Breen1% | → $32 | Initiates | → Market Perform | Get Alert |
10/11/2024 | Buy Now | 30.55% | Morgan Stanley | Terence Flynn66% | $31 → $30 | Maintains | Equal-Weight | Get Alert |
10/03/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
09/16/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
09/09/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
08/19/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
08/08/2024 | Buy Now | 47.96% | Daiwa Capital | Narumi Nakagiri23% | $28 → $34 | Upgrade | Neutral → Outperform | Get Alert |
07/31/2024 | Buy Now | 34.9% | Morgan Stanley | Terence Flynn66% | $29 → $31 | Maintains | Equal-Weight | Get Alert |
07/31/2024 | Buy Now | 39.25% | Barclays | Carter Gould59% | $30 → $32 | Maintains | Equal-Weight | Get Alert |
07/31/2024 | Buy Now | 30.55% | Wells Fargo | Mohit Bansal70% | $28 → $30 | Maintains | Equal-Weight | Get Alert |
07/31/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
07/31/2024 | Buy Now | 34.9% | UBS | Colin Bristow39% | $30 → $31 | Maintains | Neutral | Get Alert |
07/12/2024 | Buy Now | 30.55% | UBS | Colin Bristow39% | $28 → $30 | Maintains | Neutral | Get Alert |
07/10/2024 | Buy Now | 30.55% | Barclays | Carter Gould59% | $28 → $30 | Maintains | Equal-Weight | Get Alert |
07/10/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
07/01/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
06/26/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
06/20/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
06/17/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
05/02/2024 | Buy Now | 26.2% | Morgan Stanley | Terence Flynn66% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
05/02/2024 | Buy Now | 56.66% | BMO Capital | Evan David Seigerman45% | $33 → $36 | Reiterates | Outperform → Outperform | Get Alert |
04/18/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
04/15/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
04/05/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
04/01/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
03/31/2024 | Buy Now | 26.2% | Morgan Stanley | Terence Flynn66% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
03/22/2024 | Buy Now | — | Argus Research | David Toung71% | — | Downgrade | Buy → Hold | Get Alert |
03/04/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
03/01/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
02/23/2024 | Buy Now | 56.66% | Guggenheim | Vamil Divan75% | → $36 | Initiates | → Buy | Get Alert |
01/31/2024 | Buy Now | 21.85% | UBS | Colin Bristow39% | $29 → $28 | Maintains | Neutral | Get Alert |
01/31/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
01/17/2024 | Buy Now | 26.2% | UBS | Colin Bristow39% | $27 → $29 | Maintains | Neutral | Get Alert |
01/09/2024 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $45 → $45 | Reiterates | Overweight → Overweight | Get Alert |
01/04/2024 | Buy Now | 39.25% | TD Cowen | Steve Scala68% | → $32 | Downgrade | Outperform → Market Perform | Get Alert |
12/14/2023 | Buy Now | 21.85% | Wells Fargo | Mohit Bansal70% | $35 → $28 | Maintains | Equal-Weight | Get Alert |
12/14/2023 | Buy Now | 95.83% | Cantor Fitzgerald | Louise Chen54% | $75 → $45 | Maintains | Overweight | Get Alert |
12/14/2023 | Buy Now | 56.66% | Truist Securities | Robyn Karnauskas55% | $42 → $36 | Maintains | Buy | Get Alert |
12/14/2023 | Buy Now | 17.5% | UBS | Colin Bristow39% | $34 → $27 | Maintains | Neutral | Get Alert |
12/14/2023 | Buy Now | 21.85% | Barclays | Carter Gould59% | $34 → $28 | Maintains | Equal-Weight | Get Alert |
12/04/2023 | Buy Now | 82.77% | Truist Securities | Robyn Karnauskas55% | → $42 | Reiterates | Buy → Buy | Get Alert |
11/20/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
11/01/2023 | Buy Now | 47.96% | Barclays | Carter Gould59% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
11/01/2023 | Buy Now | 61.01% | Morgan Stanley | Terence Flynn66% | $39 → $37 | Maintains | Equal-Weight | Get Alert |
10/20/2023 | Buy Now | 47.96% | UBS | Colin Bristow39% | $36 → $34 | Assumes | Neutral → Neutral | Get Alert |
10/17/2023 | Buy Now | 82.77% | Truist Securities | Robyn Karnauskas55% | $62 → $42 | Maintains | Buy | Get Alert |
10/17/2023 | Buy Now | 69.72% | Morgan Stanley | Terence Flynn66% | $40 → $39 | Maintains | Equal-Weight | Get Alert |
10/17/2023 | Buy Now | 52.31% | Wells Fargo | Mohit Bansal70% | $39 → $35 | Maintains | Equal-Weight | Get Alert |
10/16/2023 | Buy Now | 43.61% | BMO Capital | Evan David Seigerman45% | $44 → $33 | Maintains | Outperform | Get Alert |
10/16/2023 | Buy Now | 52.31% | Citigroup | Andrew Baum70% | $42 → $35 | Maintains | Neutral | Get Alert |
10/16/2023 | Buy Now | 47.96% | JP Morgan | Chris Schott59% | $36 → $34 | Maintains | Neutral | Get Alert |
10/16/2023 | Buy Now | 52.31% | Wells Fargo | Mohit Bansal70% | $39 → $35 | Maintains | Equal-Weight | Get Alert |
10/16/2023 | Buy Now | 69.72% | Jefferies | Akash Tewari43% | $38 → $39 | Upgrade | Hold → Buy | Get Alert |
10/06/2023 | Buy Now | 56.66% | JP Morgan | Chris Schott59% | $39 → $36 | Maintains | Neutral | Get Alert |
10/02/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
09/18/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
09/13/2023 | Buy Now | 169.81% | Truist Securities | Robyn Karnauskas55% | → $62 | Reiterates | Buy → Buy | Get Alert |
09/05/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
08/30/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
08/22/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
08/02/2023 | Buy Now | 169.81% | Truist Securities | Robyn Karnauskas55% | $64 → $62 | Maintains | Buy | Get Alert |
08/02/2023 | Buy Now | 74.07% | Morgan Stanley | Terence Flynn66% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
08/02/2023 | Buy Now | 91.48% | BMO Capital | Evan David Seigerman45% | $45 → $44 | Maintains | Outperform | Get Alert |
07/21/2023 | Buy Now | 82.77% | Morgan Stanley | Terence Flynn66% | $43 → $42 | Maintains | Equal-Weight | Get Alert |
07/14/2023 | Buy Now | 117.59% | HSBC | Rajesh Kumar63% | → $50 | Initiates | → Buy | Get Alert |
07/11/2023 | Buy Now | 87.12% | Morgan Stanley | Terence Flynn66% | $43 → $43 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/11/2023 | Buy Now | 65.36% | Barclays | Carter Gould59% | $40 → $38 | Maintains | Equal-Weight | Get Alert |
06/29/2023 | Buy Now | 74.07% | Credit Suisse | Trung Huynh66% | $47 → $40 | Downgrade | Outperform → Neutral | Get Alert |
06/23/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
06/22/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
05/17/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
05/11/2023 | Buy Now | 65.36% | Daiwa Capital | Narumi Nakagiri23% | $51 → $38 | Downgrade | Outperform → Neutral | Get Alert |
05/03/2023 | Buy Now | 104.53% | Credit Suisse | Trung Huynh66% | $50 → $47 | Maintains | Outperform | Get Alert |
05/03/2023 | Buy Now | 74.07% | Barclays | Carter Gould59% | $43 → $40 | Maintains | Equal-Weight | Get Alert |
04/21/2023 | Buy Now | 95.83% | B of A Securities | Geoff Meacham62% | $50 → $45 | Maintains | Neutral | Get Alert |
04/12/2023 | Buy Now | 87.12% | Barclays | Carter Gould59% | $44 → $43 | Maintains | Equal-Weight | Get Alert |
04/10/2023 | Buy Now | 91.48% | Morgan Stanley | Terence Flynn66% | $45 → $44 | Maintains | Equal-Weight | Get Alert |
03/17/2023 | Buy Now | 91.48% | Wells Fargo | Mohit Bansal70% | $50 → $44 | Maintains | Equal-Weight | Get Alert |
03/06/2023 | Buy Now | 87.12% | Jefferies | Akash Tewari43% | → $43 | Initiates | → Hold | Get Alert |
02/07/2023 | Buy Now | 121.94% | Daiwa Capital | Narumi Nakagiri23% | → $51 | Upgrade | Neutral → Outperform | Get Alert |
02/01/2023 | Buy Now | 95.83% | Morgan Stanley | Terence Flynn66% | $53 → $45 | Maintains | Equal-Weight | Get Alert |
02/01/2023 | Buy Now | 226.38% | Cantor Fitzgerald | Louise Chen54% | → $75 | Reiterates | → Overweight | Get Alert |
02/01/2023 | Buy Now | 117.59% | Credit Suisse | Trung Huynh66% | $54 → $50 | Maintains | Outperform | Get Alert |
02/01/2023 | Buy Now | 130.64% | BMO Capital | Evan David Seigerman45% | $55 → $53 | Maintains | Outperform | Get Alert |
The latest price target for Pfizer (NYSE:PFE) was reported by Cantor Fitzgerald on April 22, 2025. The analyst firm set a price target for $24.00 expecting PFE to rise to within 12 months (a possible 4.44% upside). 37 analyst firms have reported ratings in the last year.
The latest analyst rating for Pfizer (NYSE:PFE) was provided by Cantor Fitzgerald, and Pfizer initiated their neutral rating.
The last upgrade for Pfizer Inc happened on August 8, 2024 when Daiwa Capital raised their price target to $34. Daiwa Capital previously had a neutral for Pfizer Inc.
The last downgrade for Pfizer Inc happened on April 8, 2025 when Goldman Sachs changed their price target from $32 to $25 for Pfizer Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pfizer, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pfizer was filed on April 22, 2025 so you should expect the next rating to be made available sometime around April 22, 2026.
While ratings are subjective and will change, the latest Pfizer (PFE) rating was a initiated with a price target of $0.00 to $24.00. The current price Pfizer (PFE) is trading at is $22.98, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.